KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Manhattan Associates (MANH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Manhattan Associates (MANH) over the last 17 years, with Q4 2025 value amounting to $328.7 million.

  • Manhattan Associates' Cash & Equivalents rose 2348.23% to $328.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $328.7 million, marking a year-over-year increase of 2348.23%. This contributed to the annual value of $328.7 million for FY2025, which is 2348.23% up from last year.
  • Manhattan Associates' Cash & Equivalents amounted to $328.7 million in Q4 2025, which was up 2348.23% from $263.6 million recorded in Q3 2025.
  • Manhattan Associates' Cash & Equivalents' 5-year high stood at $328.7 million during Q4 2025, with a 5-year trough of $153.3 million in Q2 2023.
  • Its 5-year average for Cash & Equivalents is $223.9 million, with a median of $214.4 million in 2022.
  • Per our database at Business Quant, Manhattan Associates' Cash & Equivalents surged by 16191.37% in 2021 and then plummeted by 2829.06% in 2023.
  • Manhattan Associates' Cash & Equivalents (Quarter) stood at $263.7 million in 2021, then fell by 14.5% to $225.5 million in 2022, then rose by 20.08% to $270.7 million in 2023, then fell by 1.67% to $266.2 million in 2024, then grew by 23.48% to $328.7 million in 2025.
  • Its Cash & Equivalents stands at $328.7 million for Q4 2025, versus $263.6 million for Q3 2025 and $230.6 million for Q2 2025.